(Q35040678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

N J Cooper

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

A J Sutton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

Statistical Methods in Medical Research

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

491-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

maintained by WikiProject

16 December 2019

WikiProject Mathematics

0 references

cites work

An introduction to Markov modelling for economic evaluation

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Modelling in health economic evaluation. What is its place? What is its value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Modelling in economic evaluation: an unavoidable fact of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Handling uncertainty in cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Bayesian cost-effectiveness analysis. An example using the GUSTO trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Markov Chain Monte Carlo Convergence Diagnostics: A Comparative Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Methods in health service research. An introduction to bayesian methods in health technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Bayesian estimation of cost-effectiveness ratios from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

A Bayesian approach to stochastic cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

A framework for cost-effectiveness analysis from clinical trial data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Bayesian cost-effectiveness analysis from clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

The Stroke Prevention Policy Model: linking evidence and clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

An elementary introduction to Bayesian computing using WinBUGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

The Stroke Prevention Patient Outcomes Research Team. Goals and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Investigating underlying risk as a source of heterogeneity in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Reducing the incidence of infection after caesarean section: implications of prophylaxis with antibiotics for hospital resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Bayesian approaches to random-effects meta-analysis: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Borrowing strength from external trials in a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Publication bias in clinical trials and economic analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

Effect Measures for Meta-Analysis of Trials with Binary Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0962280202SM306RA

10.1191/0962280202SM306RA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12516986%20AND%20SRC:MED&resulttype=core&format=json